Overall, these results suggested that the CNGRC binding to CD13 not only determines the homing of NGR-hTNF to tumor vessels, but also a reduction of pro-survival pathways and an increased activation of caspases, thus supporting the increased biological activity of NGR-hTNF observed in vitro. This evidence concerns the gene RTN4R and neoplasm.